Skip to main content
ACH
NYSE Trade & Services

Accendra Health Details $1.5B Debt Optimization, Reports Q1 Loss Amid Revenue Decline

Analysis by Arik Shkolnikov
Sentiment info
Neutral
Importance info
9
Price
$3.96
Mkt Cap
$302.694M
52W Low
$1.84
52W High
$9.55
Market data snapshot near publication time

summarizeSummary

Accendra Health reported a Q1 loss and declining revenue, but the filing's most critical aspect is the detailed plan for a $1.5 billion debt restructuring, which secures near-term liquidity by extending maturities at higher interest rates.


check_boxKey Events

  • Balance Sheet Optimization

    The company announced commitments to refinance over $1.5 billion in debt, including extending the Term Loan A and Revolving Credit Facility maturities, which were previously classified as current liabilities.

  • New Debt Terms

    The restructuring involves exchanging existing notes for new 9.000% senior secured first lien notes due 2032 and 9.750% senior secured second lien notes due 2033.

  • Q1 Financial Performance

    Reported a net loss of $6.47 million, an improvement from the prior year's $24.98 million net loss (which included discontinued operations). However, loss from continuing operations worsened to $6.47 million from $3.81 million year-over-year.

  • Revenue Decline

    Net revenue decreased by 6.8% to $627.78 million, primarily due to terminated commercial payor contracts.


auto_awesomeAnalysis

Accendra Health's first-quarter report highlights a critical balance sheet optimization transaction, securing commitments to refinance over $1.5 billion in debt. This move addresses significant near-term maturities, including the Term Loan A and Revolving Credit Facility, which were classified as current liabilities. While averting an immediate liquidity crisis, the restructuring involves new senior secured notes with higher interest rates (9.000% and 9.750%). Operationally, the company reported a 6.8% revenue decline and an increased loss from continuing operations, signaling ongoing challenges despite the crucial debt relief.

At the time of this filing, ACH was trading at $3.96 on NYSE in the Trade & Services sector, with a market capitalization of approximately $302.7M. The 52-week trading range was $1.84 to $9.55. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ACH - Latest Insights

ACH
May 11, 2026, 11:59 AM EDT
Filing Type: 10-Q
Importance Score:
9
ACH
May 11, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
9
ACH
May 11, 2026, 6:35 AM EDT
Filing Type: 8-K
Importance Score:
9
ACH
May 11, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
ACH
May 04, 2026, 8:34 AM EDT
Source: Reuters
Importance Score:
8
ACH
Apr 02, 2026, 6:25 AM EDT
Filing Type: DEF 14A
Importance Score:
8
ACH
Feb 20, 2026, 4:19 PM EST
Filing Type: 10-K
Importance Score:
9
ACH
Feb 19, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8